Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 128Colonic Neoplasms 54Rectal Neoplasms 49Carcinoma, Hepatocellular 29Stomach Neoplasms 23Neoplasm Metastasis 20Pancreatic Neoplasms 10Cholangiocarcinoma 9Neoplasms 8Adenocarcinoma Of Esophagus 8Esophageal Neoplasms 7Liver Neoplasms 6Gastrointestinal Neoplasms 5Biliary Tract Neoplasms 5Recurrence 4Ovarian Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Unresectable Metastatic Colorectal Cancer 2Neurotoxicity Syndromes 2Neoplastic Cells, Circulating 2Intestinal Neoplasms 2Gastrointestinal Diseases 2Gallbladder Neoplasms 2Colorectal Cancer Metastatic 2Cirrhosis, Familial, with Pulmonary Hypertension 2Breast Neoplasms 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1

Interventions

Capecitabine 2irinotecan sucrosofate 1Immunotherapy 1Folfox protocol 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Rectal Cancer × Folfox protocol × Gastrointestinal × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡